Introduction to the background, principles, and state of the art in suicide gene therapy
I Niculescu-Duvaz, CJ Springer - Molecular biotechnology, 2005 - Springer
Gene therapy is defined as a technology that aims to modify the genetic component of cells
to gain therapeutic benefits. Suicide gene therapy (or gene-directed enzyme prodrug …
to gain therapeutic benefits. Suicide gene therapy (or gene-directed enzyme prodrug …
From bench to bedside for gene-directed enzyme prodrug therapy of cancer
GU Dachs, J Tupper, GM Tozer - Anti-cancer drugs, 2005 - journals.lww.com
Gene therapy of cancer offers the possibility of a targeted treatment that destroys tumors and
metastases, but not normal tissues. In gene-directed enzyme prodrug therapy (GDEPT), or …
metastases, but not normal tissues. In gene-directed enzyme prodrug therapy (GDEPT), or …
Suicide genes for cancer therapy
D Portsmouth, J Hlavaty, M Renner - Molecular aspects of medicine, 2007 - Elsevier
The principle of using suicide genes for gene directed enzyme prodrug therapy (GDEPT) of
cancer has gained increasing significance during the 20 years since its inception. The astute …
cancer has gained increasing significance during the 20 years since its inception. The astute …
[HTML][HTML] Prodrug-activating systems in suicide gene therapy
CJ Springer, I Niculescu-Duvaz - The Journal of clinical …, 2000 - Am Soc Clin Investig
GDEPT, a form of suicide gene therapy, aims to maximize the effect of a toxic drug and
minimize its systemic effects by generating the drug in situ within the tumor. In the first step in …
minimize its systemic effects by generating the drug in situ within the tumor. In the first step in …
Bystander effects in enzyme/prodrug gene therapy
F Paillard - Human gene therapy, 1997 - liebertpub.com
Enzyme/prodrug gene therapy is a widely used approach in human gene therapy, with its
use in 1996, involving about 1 0% of the patients undergoing clinical trials (Marcel and …
use in 1996, involving about 1 0% of the patients undergoing clinical trials (Marcel and …
Progress and problems with the use of suicide genes for targeted cancer therapy
Among various gene therapy methods for cancer, suicide gene therapy attracts a special
attention because it allows selective conversion of non-toxic compounds into cytotoxic drugs …
attention because it allows selective conversion of non-toxic compounds into cytotoxic drugs …
[HTML][HTML] Enzyme/prodrug systems for cancer gene therapy
The use of enzyme/prodrug system has gained attention because it could help improve the
efficacy and safety of conventional cancer chemotherapies. In this approach, cancer cells …
efficacy and safety of conventional cancer chemotherapies. In this approach, cancer cells …
Use of suicide genes for cancer gene therapy: study of the different approaches
G Vassaux, P Martin-Duque - Expert opinion on biological therapy, 2004 - Taylor & Francis
Cancer is a disease of high incidence for which conventional treatments are not necessarily
effective. There is a need for the development of new alternative strategies. Among them …
effective. There is a need for the development of new alternative strategies. Among them …
Suicide gene therapy in cancer: where do we stand now?
S Duarte, G Carle, H Faneca, MCP de Lima… - Cancer letters, 2012 - Elsevier
Suicide gene therapy is based on the introduction into tumor cells of a viral or a bacterial
gene, which allows the conversion of a non-toxic compound into a lethal drug. Although …
gene, which allows the conversion of a non-toxic compound into a lethal drug. Although …
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma
GM Seo, RS Rachakatla, S Balivada, M Pyle… - Molecular biology …, 2012 - Springer
Gene-directed enzyme prodrug therapy (GDEPT) has been investigated as a means of
cancer treatment without affecting normal tissues. This system is based on the delivery of a …
cancer treatment without affecting normal tissues. This system is based on the delivery of a …